Joinn Laboratories(China)Co.,Ltd. provided earnings guidance for the six months ended 30 June 2023. For the period, the company expected that the revenue will be approximately RMB 973.2332 million to RMB 1,050.9213 million, and will increase approximately RMB 196.3521 million to RMB 274.0402 million as compared with the data for the corresponding period of last year, representing a period-on-period increase of approximately 25.3% to 35.3%. It is expected that the net profit attributable to the shareholders of the Company will be approximately RMB 72.7657 million to RMB 109.8777 million, and will decrease by approximately RMB 261.2419 million to RMB 298.3539 million as compared with the data for the corresponding period of last year, representing a period-on-period decrease of approximately 70.4% to 80.4%.